HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Hyperfine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.78+0.02 (+2.97%)
Close on Oct 19, 2026
- Market cap
- $77.56M
- P/E (TTM)
- –
- Dividend yield
- –
Hyperfine statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Hyperfine | Industry median |
|---|---|---|
| Market Cap | $82.42M | $229.23M |
| Enterprise Value | $52.20M | $194.73M |
| PS Ratio | 4.98 | 3.14 |
| PB Ratio | 2.24 | 3.19 |
| P/TBV Ratio | 2.24 | 4.69 |
Enterprise value
| Measure | Hyperfine | Industry median |
|---|---|---|
| EV / Sales | 3.16 | 2.93 |
Income (trailing twelve months)
| Measure | Hyperfine | Industry median |
|---|---|---|
| Revenue | $16.54M | $102.39M |
| Gross Profit | $8.50M | $60.36M |
| Operating Income | -$33.62M | -$4.31M |
| Pretax Income | -$34.85M | -$2.26M |
| Net Income | -$34.85M | -$6.57M |
| EBITDA | -$33.62M | -$1.98M |
| EPS (Diluted) | -$0.38 | -$0.07 |
Margins
| Measure | Hyperfine | Industry median |
|---|---|---|
| Gross Margin | 51.4% | 55.1% |
| Operating Margin | -203.3% | -6.04% |
| Pretax Margin | -210.8% | -4.11% |
| Profit Margin | -210.8% | -10.5% |
| EBITDA Margin | -203.3% | -2.67% |
| FCF Margin | -166.5% | -0.30% |
Returns
| Measure | Hyperfine | Industry median |
|---|---|---|
| Return on Equity (ROE) | -97.0% | -19.2% |
| Return on Assets (ROA) | -64.4% | -13.3% |
| Return on Invested Capital (ROIC) | -327.0% | -4.11% |
| Return on Capital Employed (ROCE) | -63.0% | -9.07% |
Growth
| Measure | Hyperfine | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 53.2% | 8.85% |
| Revenue Growth (3Y CAGR) | 25.8% | 7.08% |
| Revenue Growth (5Y CAGR) | 115.2% | 11.8% |
Balance sheet
| Measure | Hyperfine | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $43.46M | $37.33M |
| Total Debt | $13.24M | $72.66M |
| Net Cash (Debt) | $30.22M | $3.92M |
| Net Cash Per Share | $0.28 | $0.28 |
| Equity (Book Value) | $36.76M | $57.36M |
| Book Value Per Share | $0.35 | $2.81 |
| Tangible Book Value | $36.76M | $10.71M |
| Working Capital | $49.61M | $54.64M |
Financial position
| Measure | Hyperfine | Industry median |
|---|---|---|
| Current Ratio | 6.15 | 2.50 |
| Quick Ratio | 4.95 | 1.54 |
| Debt / Equity | 0.36 | 0.38 |
Cash flow (trailing twelve months)
| Measure | Hyperfine | Industry median |
|---|---|---|
| Operating Cash Flow | -$27.07M | -$653.46K |
| Capital Expenditures | -$465.00K | -$3.69M |
| Free Cash Flow | -$27.53M | -$835.02K |
| FCF Per Share | -$0.26 | -$0.02 |
Efficiency
| Measure | Hyperfine | Industry median |
|---|---|---|
| Asset Turnover | 0.31 | 0.59 |
| Inventory Turnover | 1.38 | 2.21 |
| Revenue Per Employee | $162.13K | $322.75K |
| Profits Per Employee | -$341.69K | -$52.11K |
| Employee Count | 102 | 197 |
Dividends and yields
| Measure | Hyperfine | Industry median |
|---|---|---|
| Earnings Yield | -42.3% | -6.92% |
| FCF Yield | -33.4% | -0.62% |
Shares
| Measure | Hyperfine | Industry median |
|---|---|---|
| Shares Outstanding | 106,049,000 | 44,856,700 |
| Shares Change (YoY) | 23.8% | 3.35% |
| Float | 86,873,200 | 36,934,400 |
| Shares Held by Insiders | 18.1% | 10.6% |
| Shares Held by Institutions | 20.6% | 63.5% |
Taxes
| Measure | Hyperfine | Industry median |
|---|---|---|
| Income Tax | $0 | $1.52M |
Scores
| Measure | Hyperfine | Industry median |
|---|---|---|
| Altman Z-Score | -6.40 | 1.95 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Hyperfine's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.